Detalles de la búsqueda
1.
A combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infection.
J Virol
; 86(19): 10857-61, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22837204
2.
The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection.
J Virol
; 85(11): 5252-61, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21411521
3.
Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment.
J Infect Dis
; 202(10): 1538-42, 2010 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20923373
4.
Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type 1.
J Virol
; 83(15): 7783-8, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19474105
5.
Systemic cytokine levels show limited correlation with risk of HIV-1 acquisition.
J Acquir Immune Defic Syndr
; 66(2): 135-9, 2014 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24413043
6.
Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA.
J Acquir Immune Defic Syndr
; 60(5): 511-8, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22592588
Resultados
1 -
6
de 6
1
Próxima >
>>